证券记录 · 已归档季度
ELAN
Elanco Animal Health Incorporated · Healthcare · Drug Manufacturers - Specialty & Generic
17被追踪持有人
+1Δ持有人
175.40M持有股份
$2.58B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +6.2% ·
股份流向 -15.4% ·
净新建仓位 +5.9%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 276.62K | $5.90M | n/a | n/a |
| Q2 2026 | 130 | +5 | 426.69M | $10.50B | +12 | −6 |
| Q1 2026 | 127 | -2 | 403.59M | $9.65B | +6 | −9 |
| Q4 2025 | 128 | +1 | 433.50M | $9.81B | +4 | −2 |
| Q3 2025 | 20 | -1 | 348.71M | $7.02B | n/a | −2 |
| Q2 2025 | 19 | +2 | 313.01M | $4.47B | +3 | −1 |
| Q1 2025 | 14 | -2 | 167.03M | $1.75B | +1 | −3 |
| Q4 2024 | 16 | -2 | 168.00M | $2.03B | n/a | −2 |
| Q3 2024 | 17 | +1 | 175.40M | $2.58B | +1 | n/a |
| Q2 2024 | 16 | n/a | 207.32M | $2.99B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 83.32M | -0.3% | $1.22B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 52.58M | -0.4% | $772.33M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 8.99M | -4.5% | $132.08M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 7.87M | +0.8% | $115.62M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 7.49M | -41.4% | $110.09M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 4.01M | +19.2% | $58.87M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 7 | Norges Bank ✦ (被动) | 3.57M | -7.9% | $52.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.04M | -89.2% | $44.59M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 9 | Point72 Asset Management ✦ | 1.34M | 新增 | $19.71M | 0.1% | New | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 1.03M | -59.4% | $15.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 700.00K | -49.9% | $10.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 479.54K | +1853.8% | $7.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 398.50K | -71.2% | $5.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 338.96K | +111.1% | $4.98M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 197.44K | +177.2% | $2.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 35.33K | -1.4% | $519,042 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 25.68K | +11.1% | $377,195 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $19.71M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 512 持有人, 543.55M 股份, $11.98B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 20
Kurzius Lawrence Erik
Director · 40.00K 股 @ 23.40 · $935,920
Aug 18
O'Neill Shiv
Officer · GC AND CORP SEC · 4.00K 股 @ 23.58 · $94,273
Aug 12
Harrington Michael J
Director · 5.00K 股 @ 21.82 · $109,100
Aug 07
Herendeen Paul
Director · 10.00K 股 @ 23.68 · $236,850
Aug 07
VanHimbergen Robert M
Officer · EVP and CFO · 4.20K 股 @ 23.08 · $96,926
公开市场卖出 (S)
Oct 15
Bettington Timothy J
Officer · 4.35K 股 · $100,050
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 14
SC 13G: DIMENSIONAL FUND ADVISORS LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据